Boston Scientific Corporation vs Under Armour Inc Class A — how do they compare? Boston Scientific Corporation trades at $51.1 (market cap $74.19B), while Under Armour Inc Class A trades at $5.24 (market cap $2.26B). The key difference: Boston Scientific Corporation is far larger — about 32.8× Under Armour Inc Class A's market cap, and Under Armour Inc Class A is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | UA | |
|---|---|---|
Market Cap | $74.19B | $2.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $108.14 | $7.88 |
52-Week Low | $42.63 | $3.96 |
Enterprise Value | $86.27B | $3.24B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →